Posts tagged “GSK”
A closely watched study of GlaxoSmithKline plc's Breo Ellipta respiratory treatment failed to prove that it extends patients' lives, denying the drugmaker a much-needed marketing edge in its most lucrative - but declining - medicine category.
GlaxoSmithKline has struck another major deal with Novartis. This time the drug giants are teaming up for a deal worth more than $1 billion plus royalties to GSK for an experimental multiple sclerosis drug. The deal will help GSK focus on other priorities, a top executive says.
Bezos disputes critical Amazon story; GSK plant reopens; Lenovo's new storage move; report links AT&T, NSA
In today's Bulldog wrapup of technology and life science news: Jeff Bezos disputes a New York Times story critical of the company's work environment; GSK reopens its plant in Zebulon; Lenovo launches a new storage product; and a New York Times report links AT&T with the NSA.
Pfizer-GSK rumors; Apple ups hiring of women, minorities; Dell's new Chromebooks; Pure Storage IPO; Tesla raising $500M
In today's wrapup of technology and life science news: Rumors heat up that Pfizer wants GSK; Apple reports big increase in hiring of women and minorities; Dell's new Chromebooks; EMC, NetApp rival Pure Storage eyes IPO; and Tesla aims to raise $500 million.
Pharmaceutical company GlaxoSmithKline (NYSE: GSK) anticipates resuming production at its Zebulon site in the next three days after bacteria that causes Legionnaires' disease was found in the cooling towers, a company spokesperson said Wednesday.
Phoundry Pharmaceuticals, a startup spun out from GlaxoSmithKline, has found eight investors and is looking for more as it aims to raise $1 million. The firm is targeting diabetes. It's also already backed by the N.C. Biotechnology Center.
Takeover talk sparks GSK shares; AT&T workers' contract expires; Tesla's cash burn; Buffet's bad quarter
In today's Bulldog wrapup of technology and life science news: GlaxoSmithKline shares are climbing on takeover talk; AT&T workers in southeast are without a contract; Tesla is burning $4,000 in cash for very car sold; and a bad quarter for Warren Buffet's investments.
GSK rehires China exec; automakers buy Nokia map biz; Yahoo buys style-tip site; Zuckerbergs expecting; Windows 10 scam warning
In today's wrapup of technology and life science news: GSK has rehired an executive linked to its China bribery scandal; German automakers are buying Nokia's map business in a step toward driverless cars; Yahoo buys a web startup; the Zuckerbergs are expecting; and a warning about a free Windows update scam.
In a conference call, GlaxoSmithKline's top executive is asked if he would consider "pairing up" with another drug company. Back in May, an analyst started talk of a "PfizerKline" merger. GSK's CEO Andrew Witty notes a merger would be a "big issue to cross."
As many as 200 former GlaxoSmithKline employees who were transferred to life science services firm Parexel earlier this year are reportedly being laid off today. However, the Boston-based company which has a large presence in the Triangle, isn't talking.
Apple stock slides; Microsoft's $8.4B write-down; GSK suit; Yahoo's loss; Facebook loses warrant fight
In today's Bulldog wrapup of technology and life science news: Apple stock tumbles as it stays coy on watch sales; Microsoft takes a huge write-down; GSK sues a software developer; Yahoo reports a quarterly bummer; and Facebook loses in warrant battle.
GSK's HIV drug deal with China; inside IBM's Wimbledon bunker; Red Hat adds SAP to cloud; Tesla sets record; Wi-Fi in Cuba
In today's wrapup of technology and life science news: GSK makes an HIV drug deal with China; going inside IBM's bunker at Wimbledon; Red Hat adds SAP support to cloud services at Amazon; Tesla sets a record for car deliveries; and Cuba gets Wi-Fi hot spots.
Apple Watch forecast cut; robot kills worker; IBM's $1.5B chip deal closes; GSK vaccine, narcolepsy linked; AT&T-DirecTV deal nears OK
In today's Bulldog wrapup of technology and life science news: An analyst says Apple Watch sales are slowing and he cuts forecast; a robot kills a worker in Germany; IBM closes on its $1.5 billion deal to dump its chip business; a GSK drug is linked to narcolepsy outbreak by study; and AT&T reportedly wins Justice Department OK for its DirecTV deal.
GSK sells 2 vaccines to Pfizer; Google 'revenge porn' crackdown; Tesla for the sky; Polish airline hack; eBay, Craigslist settle
In today's Bulldog wrapup of tech and life science news: GSK is selling two meningitis vaccines to Pfizer; Google cracks down on "revenge porn;' a Tesla for the skies?; Polish airline is hacked; and eBay settles a dispute with Craigslist.
GSK funds 3 startups; Congress eyes data breach; HealthCare.gov risk; facial recognition debate; Triangle Cleantech update
In today's Bulldog wrapup of technology and life science news: GlaxoSmithKline is funding three more startups at an incubator in San Diego; Congress looking into huge federal data breach; is HealthCare.gov data at risk?; facial recognition standards talks hit a roadblock; and an added position for the head of the Research Triangle Cleantech Cluster.
Drug giant GlaxoSmithKline received two doses of good news this week. An FDA committee on Thursday recommended its drug be approved for use in adults. Plus a new study says a cervical cancer vaccine appears effective with one dose.
Where there is smoke is there fire when it comes to rumors that Pfizer might try to buy troubled GlaxoSmithKline? A Wall Street analyst is the latest to speculate that a mega merger could be in the works.
Drug giant GlaxoSmithKline is teaming up with the University of North Carolina at Chapel Hill in an attempt to find a cure for AIDS. The two will form a new company called Qura Therapeutics and will launch an "HIV Cure Center" in Chapel Hill. GSK is committing $20 million over the next five years to fund the project.